Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)

M van Heijl; JJB van Lanschot; LB Koppert; MI van Berge Henegouwen; K Muller; EW Steyerberg; H van Dekken; BPL Wijnhoven; HW Tilanus; DJ Richel; ORC Busch; JF Bartelsman; CCE Koning; GJ Offerhaus; A van der Gaast

doi:10.1186/1471-2482-8-21

Study protocol

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)

M van Heijl^*, JJB van Lanschot, LB Koppert, MI van Berge Henegouwen, K Muller, EW Steyerberg, H van Dekken, BPL Wijnhoven, HW Tilanus, DJ Richel, ORC Busch, JF Bartelsman, CCE Koning, GJ Offerhaus and A van der Gaast

* Corresponding author: M van Heijl m.vanheijl@amc.uva.nl

BMC Surgery 2008, 8:21 doi:10.1186/1471-2482-8-21

No comments have yet been made on this article.

BMC Surgery

Viewing options

Associated material

Tools

Share this article

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)

BMC Surgery

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)